Blow for Novartis as heart failure drug flops

Novartis’ heart failure drug serelaxin has failed in a late-stage trial, casting major doubts over the drug once seen as a potential blockbuster.

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More